A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high‐grade serous carcinoma development
Cheryl A. Sherman‐Baust(National Institute on Aging), Patrice J. Morin(National Institutes of Health), Ichiro Miyoshi(Hokkaido University of Science), Yoshihiko Araki(Yamagata University), Kevin G. Becker(University of Connecticut), Elin Lehrmann(National Institutes of Health), Ie‐Ming Shih(Johns Hopkins University), Tian‐Li Wang(Sichuan University), Minoru S.H. Ko(Elixir Medical (United States)), Yongqing Zhang(Central South University), Robert J. Kurman(Johns Hopkins University), Tomokazu Amano(Elixir Medical (United States)), Blanca L. Valle(Johns Hopkins University), Elisabetta Kuhn(Johns Hopkins University)
Cited by 137
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease.
|Proceedings of the National Academy of Sciences|1982|2.2k
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k